GlassScriptPhysician profile
Ward W Ohlhausen
NPI 1093714370
$2,768.12
in general payments reported to CMS, 2019-2025
34 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2020: $401 · 2021: $666 · 2022: $382 · 2023: $373 · 2024: $168 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.26 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $410.96 | 2019-2022 | |
| Abbvie INC. | $379.90 | 2019-2023 | |
| Astellas Pharma US INC | $252.08 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $240.19 | 2019-2025 | Evenity, Prolia |
| Pfizer INC. | $203.81 | 2019-2023 | |
| Intuitive Surgical, INC. | $156.64 | 2019-2020 | |
| Ethicon US, LLC | $85.71 | 2020 | |
| Therapeuticsmd, INC. | $79.31 | 2021-2022 | |
| Millicent US INC | $78.48 | 2025 | Femring, Intrarosa, Femlyv |
| Medtronic, INC. | $68.06 | 2021 | |
| Allergan, INC. | $67.11 | 2019-2020 | |
| Biogen, INC. | $62.69 | 2024 | Zurzuvae |
| Mayne Pharma Commercial LLC | $59.38 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $57.43 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $54.87 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $54.07 | 2023 | Exparel |
| Hologic Sales and Service, LLC | $50.02 | 2019-2025 | Aptima, Thinprep 2000 Processor, Third Wave |
| Channel Medsystems, INC. | $46.27 | 2022 | |
| Scynexis, INC. | $42.88 | 2022 | |
| Boston Scientific Corporation | $31.41 | 2019-2024 | Advantage System |
| Amag Pharmaceuticals, INC. | $28.28 | 2019-2020 | |
| Exeltis, USA INC. | $27.52 | 2023 | Slynd |
| Organon LLC | $27.07 | 2023-2025 | Nexplanon |
| Evofem Biosciences, INC. | $26.90 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.38 | 2021-2022 | |
| Lupin INC. | $24.19 | 2019 | |
| Davol INC. | $21.77 | 2021 | |
| Molnlycke Health Care US, LLC | $20.46 | 2023 | Mepilex Border, Mepilex Ag, Mepilex Border Ag |
| Mylan Pharmaceuticals INC. | $19.22 | 2021 | |
| Urovant Sciences INC | $16.40 | 2021 | |
| Avion Pharmaceuticals | $13.96 | 2022 | |
| Agile Therapeutics, INC. | $13.35 | 2022 | |
| Bsn Medical INC | $12.35 | 2019 | |
| Covidien LP | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ward Ohlhausen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.